ArticlePeerJ2026
Behavioral and biological alterations following transplantation of ASD-associated gut microbiota in mice.
Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Alterations in the gut microbiota have been increasingly reported in individuals with autism spectrum disorder (ASD). However, the extent to which ASD-associated microbial communities are linked to behavioral and host biological changes remains to be clarified. Methods: Fecal microbiota transplantation (FMT) was performed using samples from children with ASD or typically developing (TD) controls into antibiotic-pretreated mice. Behavioral performance was evaluated using open field, social interaction, and spatial learning paradigms. Gut microbial composition was assessed by 16S rRNA gene sequencing. Peripheral immune-related parameters were assessed, including circulating regulatory T cells and serum cytokine profiles. Histological and molecular analyses were conducted in the terminal ileum and hippocampus, including immunohistochemistry, Western blotting, exploratory brain proteomics, and targeted qRT-PCR validation. Results: Mice receiving ASD-associated microbiota displayed altered behavioral performance, including reduced sociability and impaired spatial learning. 16S rRNA sequencing revealed distinct gut microbial profiles between ASD-FMT and TD-FMT groups, with increased abundance of Enterobacteriaceae and related taxa in ASD-FMT mice. Peripheral analysis showed reduced regulatory T cell levels and altered serum cytokine profiles. Histological examination identified changes in intestinal architecture and increased expression of glial markers in the hippocampus. Proteomic analysis indicated differential expression of proteins enriched in pathways related to neural structural organization and metabolic processes. Conclusions: These findings indicate that gut microbiota derived from children with ASD is associated with coordinated behavioral, peripheral immune-related, and brain histological changes in mice. This study provides integrative evidence supporting associations between ASD-associated microbial features and coordinated behavioral and biological alterations in the host.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.